Biogen Inc. buy Haans
Start price
19.07.16
/
50%
€236.03
Target price
02.08.16
€280.00
Performance (%)
23.10%
End price
02.08.16
€290.55
Summary
This prediction ended on 02.08.16 with a price of €290.55. The BUY prediction by Haans finished with a performance of 23.10%. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 3.119% | 3.119% | -28.472% | -8.929% |
| iShares Core DAX® | 4.015% | 2.971% | 16.492% | 19.144% |
| iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% | 50.636% |
| iShares Nikkei 225® | -0.826% | -5.057% | 14.566% | 2.379% |
| iShares S&P 500 | 2.330% | 0.720% | 30.194% | 44.181% |
Comments by Haans for this prediction
In the thread Biogen Inc. diskutieren
Gewinnt an Stärke...
Biogen, wie auch der gesamte Biotech-Sektor gewinnt deutlich an Stärke. Biotech wird bald wieder zu den Outperformern gehören. Es ist an der Zeit sich langsam zu positionieren.